Fewer food aversions or milder nausea are often mentioned as reasons microdosing GLP-1 feels easier to maintain in real-world settings
People commonly experience some or all of the following side effects after stopping GLP-1 medications, says Goddard: Increased hunger (often noticeably stronger) Food noise, often described as the persistent mental chatter about eating and cravings Weight regain, which research shows can begin within weeks Changes in blood sugar control, particularly for people with type 2 diabetes Loss of some cardiometabolic benefits gained during treatment Improvement in GLP-1-related side effects such as nausea, constipation and bloating Not everyone experiences every one of these changes, and their severity varies widely
Nausea is by far the most frequently reported adverse effect across every GLP-1 receptor agonist studied
Homozygous NKO mice exhibit embryonic lethality [68], whereas heterozygous NKO mice exhibit IGT due to impaired insulin secretion [68] and heart failure due to progressive mitochondrial dysfunction induced by pressure overload [69]
Fatigue and energy changes Some people experience fatigue on GLP-1 medications , especially during the first few weeks